×

Loading...
Ad by
  • 推荐 OXIO 加拿大高速网络,最低月费仅$40. 使用推荐码 RCR37MB 可获得一个月的免费服务
Ad by
  • 推荐 OXIO 加拿大高速网络,最低月费仅$40. 使用推荐码 RCR37MB 可获得一个月的免费服务

纽时报道,CDC隐瞒了很大部分数据没公布,50岁以下的打了booster没啥区别。The C.D.C. Isn’t Publishing Large Portions of the Covid Data It Collects

The agency has withheld critical data on boosters, hospitalizations and, until recently, wastewater analyses.
Report

Replies, comments and Discussions:

  • 枫下家园 / 医药保健 / Pfizer to Ask US Regulators to Authorize Second Booster Due to Waning Effectiveness: CEO +6
    Pfizer plans to ask U.S. regulators to grant emergency use authorization for a second booster of its COVID-19 ...
    • 针针不休!1?他们不是许诺专门对付omicron的疫苗吗?都已经3月了,咋又拿老东西出来忽悠人啊?! +12
    • 这药水既不安全、也不有效。 +11
    • PFIZER告诉大家: 三针疫苗护照(证明)已经作废了,只有四针疫苗护照(证明)才有效 :-) +9
    • 躺着赚钱赚疯了。 +3
      • 看人家赚钱眼红,战争来了,生产武器的不该赚钱吗? +1
    • 纽时报道,CDC隐瞒了很大部分数据没公布,50岁以下的打了booster没啥区别。The C.D.C. Isn’t Publishing Large Portions of the Covid Data It Collects +2
      The agency has withheld critical data on boosters, hospitalizations and, until recently, wastewater analyses.